Virginia Clinical Research, Inc.   Report issue

For profit Phase 2
Founded: Norfolk VA United States (1981)

Organization Overview

First Clinical Trial
2006
NCT00274352
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Pariser, Robert J., M.D. | Virginia Clinical Research, Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 2)

Keloid (Phase 2)

Lichen Planus (Phase 2)

Onychomycosis (Phase 2)

Recurrence (Phase 2)

Sarcoidosis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 6